DOI: 10.4244/EIJV7I12A231

Atypical “black hole” phenomenon after treatment of sirolimus stent restenosis with a paclitaxel-coated balloon

José A. Linares Vicente1*, MD; Antonela Lukic1, MD; Nieves Gonzalo López2, MD, PhD; Jose R. Ruiz Arroyo1, MD

The “black hole” phenomenon is described as a series of small anechogenic spherical images (50-300 µm) inside a late restenotic neointimal hyperplasia dorsal to sirolimus-coated stent struts implanted in failed intracoronary brachytherapy. This is seen in vein grafts or bare metal stent restenosis exclusively. Histologically, there is a hypocellular matrix with abundant proteoglycans areas, without mature elastin or collagen1.

A coronariography due to angina was performed in a 66-year-old diabetic female two months after a first sirolimus-stent restenosis on left anterior descending coronary artery (LAD) treated with a paclitaxel-coated balloon. Optical coherence tomography showed severe restenosis associated with distal stent underexpansion and an atypical “black hole” phenomenon in proximal neointimal hyperplasia tissue: low reflective and big size elliptic areas (1-1.5 mm of large diameter) localised between the stent struts and next to the native vessel but separated from lumen (Figure 1, Moving image 1). Previous paclitaxel-coated balloon angioplasty could have promoted apoptosis, internal elastic lamina disruption, and decreased medial smooth muscle cells and collagen content2 which could explain the holes appearance since they are localised between the struts, where sirolimus activity is supposed to be lower.

Figure 1. Optical coherence tomography of LAD sirolimus stent showing the atypical and large “black hole” phenomenon in a neointimal hyperplasia.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Supplementary data

To read the full content of this article, please download the PDF.

video
Volume 7 Number 12
Apr 20, 2012
Volume 7 Number 12
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-23-00052 Mar 18, 2024
Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation
Joner M and Wild L
free

Debate

10.4244/EIJ-E-24-00005 Mar 18, 2024
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
McEntegart M et al
free

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved